Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics Partners With Biomarker Collaborative to Provide Lung Cancer Resources

NEW YORK – NeoGenomics announced on Monday that it has entered a strategic partnership with the Biomarker Collaborative to help cancer patients with certain biomarkers find resources.

The Biomarker Collaborative is a community of biomarker groups with a focus on helping patients navigate the healthcare system and ensuring they receive comprehensive biomarker testing. It also advocates to increase screening and support access to clinical trials.

Under the agreement, when a patient's lung cancer biomarker is identified with NeoGenomics' tests, the results will include a resource page with education about the biomarker and connections to support groups. The resource page "is a discussion starting point helping empower patients to better understand their diagnosis with the support of peers walking a similar journey," NeoGenomics said in a statement.

"Both the patient and the patient's oncologist will now see in the actual report ordered by the oncologist and issued by NeoGenomics that there is a biomarker group directly relevant to the patient's diagnosis," John Hallick, co-president of the Biomarker Collaborative, said in a statement.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.